Decheng Capital

Venture Capital Active United States

Last updated 2026-06-18

Portfolio

1

in our dataset

Rounds participated

1

Rounds led

0

Rounds' value

$111.0M

total disclosed, rounds participated

Stages

—

Portfolio · 1

CAR-T Cell Therapies for Treating Cancer

1 round $111.0M committed Latest: 2022-01